Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies

This study has been terminated.
Sponsor:
Information provided by (Responsible Party):
BioMarin Pharmaceutical
ClinicalTrials.gov Identifier:
NCT01399840
First received: July 13, 2011
Last updated: May 21, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2014
  Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)